Modesto Orozco’s lab has published a paper in Chemical Communications about a therapeutic tool to prevent treatment resistance in breast cancer.
The tool has been tested in tumour cells in vitro and will now need to be tested in animal models before moving on to the development of a valid treatment for patients.
The Montserrat School, IRB Barcelona, and the Fundació Catalunya La Pedrera take stock of their 3-year joint project that has brought about a change in the teaching method at this primary school.
The Institute will be giving a workshop entitled “Deciphering the code of cancer”
Coinciding with #GivingTuesday, today IRB Barcelona is launching its donation campaign for the forthcoming holiday season.
Basic research paves the way towards the medicine of the future. Donations made to research speed up discoveries
The announcement made yesterday by the Chinese scientist He Jiankui that twins Lulu and Nana had been born after editing their DNA has brought about a storm of criticisms and generated alarm among the scientific community and society. (*Chinese researcher claims first gene-edited babies. Associated Press). The gene editing of embryos may become (or not) a reality in the future, but right now it is clearly premature.
The Chinese researcher He Jiankui has crossed all the red lines because before this technology can go any further, ethical issues...
A team headed by ICREA researchers Salvador Aznar Benitah and Fran Supek concludes that care should be taken with drugs that inhibit epigenetic factors.
Published in Nature Cell Biology, the study is a collaboration between a biomedical lab and a computational lab at IRB Barcelona.
Since 2017, the Croatian researcher has been leading a team of 10 scientists in the Genome Data Science lab.
With Supek’s new appointment, IRB Barcelona now has 14 ICREA researchers.
Researchers at IRB Barcelona modify chlorotoxin—a small protein present in scorpion venom with blood-brain barrier permeability—to transport drugs into the brain.
The barrier, which protects the brain, prevents drugs used for the treatment of neurological diseases and brain tumours from entering the organ.
A study in mice done at IRB Barcelona and CNAG-CRG explains that dermal fibroblasts lose their cell identify over time and with it their capacity to produce and secrete collagen and other proteins.
The Spanish Association of Cancer Research recognizes his work and grants him the ASEICA Young Investigator Award 2018.
The award ceremony will be held in Valencia on 6, 7 and 8 November.